Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;88(1):39-44.
doi: 10.1177/0022034508328072.

Phosphate regulates osteopontin gene transcription

Affiliations

Phosphate regulates osteopontin gene transcription

S Fatherazi et al. J Dent Res. 2009 Jan.

Erratum in

  • J Dent Res. 2011 Jun;90(6):817

Abstract

Extracellular inorganic phosphate (ePi) is a key regulator of cementoblast behavior, both in vivo and in vitro, and results in a marked increase in osteopontin expression in vitro. To examine the molecular mechanisms involved in ePi induction of osteopontin gene expression, we transfected a series of osteopontin promoter-luciferase constructs into OCCM-30 cementoblasts. Our results demonstrate that ePi can directly induce osteopontin gene transcription. The region responsive to ePi signaling was localized to a 53-bp region of the promoter between -1454 and -1401 that contains a glucocorticoid response element (GRE). Mutation of the GRE abolished the ePi response, suggesting that glucocorticoid receptor (GR) signaling is required for ePi-mediated transcription. In addition, treatment of cells with the GR antagonist RU-486 (Mifepristone) prevented promoter activation by ePi. The results presented support a model demonstrating that inorganic phosphate regulates OPN gene transcription in cementoblasts through a pathway that requires a functional GR.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phosphate activation of the OPN gene in cementoblasts. (A) The -1454/+ 5 OPN-luc construct was transfected into OCCM-30 cells, and cells were incubated with ePi for 12 hrs before being harvested. Results are shown normalized to the Renilla luciferase activity ± 1 SD. EV (empty vector) and pGL3 C represent cells transfected with pGL3-Basic and pGL3-Control, respectively. The mean Firefly/Renilla luciferase values (± SE) were: OPN –ePi/EV, 167.6 ± 5; OPN+ 2mM ePi/EV, 370 ± 29.5; and OPN+ ePi 4mM/EV, 388 ± 15.8. (B) Time-course of Pi activation of the OPN promoter. Cells were transfected with -1454/+ 5 OPN-luc and treated with 3 mM ePi (+ Pi) or media (-ePi) for 6, 12, and 24 hrs before being harvested. The mean Firefly/Renilla luciferase values of OPN promoter/EV (± SE) were: 6 hrs, 5.82 ± 0.6, 10.42 ± 1.2 (- Pi, + Pi); 12 hrs, 21.6 ± 1.6, 41.85 ± 1.7 (- Pi, + Pi); and 24 hrs, 22.22 ± 1.2, 9.6 ± 1.02 (- Pi, + Pi). (C) OPN mRNA expression measured by Q-PCR. Cells were treated with 5 mM ePi (P) or media only (NT) for between 1 and 48 hrs and then harvested for RNA analysis. Q-PCR was performed as described in MATERIALS & METHODS. Results are shown normalized to GAPDH. These experiments were performed in triplicate and represent 1 of the 5 experiments. *P ≤ 0.05.
Figure 2.
Figure 2.
Deletion mapping to identify the phosphate-responsive region. (A) Diagram of the OPN constructs generated by restriction enzyme digestion or PCR. The distal 300 bp of the mouse OPN promoter sequence contained in the -1454/+5 OPN-luc construct is shown. The GRE motif is underlined in bold. (B,C) Luciferase activity of the OPN promoter constructs in the absence (- Pi) and presence (+ Pi) of 3 mM ePi. (B) Mean Firefly/Renilla values ± SE for the OPN constructs/EV (left to right) were: 33.66 ± 8.8, 82.8 ± 7.4, 57.0 ± 6.2, and 95.4 ± 10.9. (C) Mean Firefly/Renilla values ± SE for the OPN constructs /EV (left to right) were: 20 ± 2.9, 40 ± 7.5, 15 ± 3.2, 20 ± 5.8, 16 ± 5.9, 24 ± 11.4, 20 ± 3.4, and 22 ± 6.4, respectively. EV represents a control transfection with pGL3-Basic. All results are shown normalized to Renilla luciferase activity. These experiments represent the mean of triplicates and represent 1 of the 4 experiments. *P ≤ 0.05.
Figure 3.
Figure 3.
Phosphate induction of the OPN promoter requires a Glucocorticoid Receptor Element. OPN-luc promoter constructs were prepared by PCR and ligated into a PGL3-Promoter vector. Constructs were transfected into OCCM-30 cells as described in MATERIALS & METHODS. Cells were treated with 3 mM Pi and analyzed for luciferase activity as described in Figs. 1 and 2. (A) Mean Firefly/Renilla values ± SE for the OPN constructs /EV (left to right) were: 26.15 ± 1, 40.94 ± 2.5, 19.23 ± 0.7, 33.4 ± 6.1, 22.42 ± 2.95, 37.9 ± 2.5, 26 ± 2.9, 24 ± 2.1, 19.4 ± 1.2, and 19.54 ± 5.2, respectively. (B) Mutagenesis of the OPN GRE prevents Pi induction of promoter activity. Cells were transfected with the indicated mutant constructs that contained 2 or 4 base substitutions in the 3’ half-site of the GRE, and then tested for Pi responsiveness. The control construct (denoted TGTTCT) was -1454/-1134 OPN-luc. Mean Firefly/Renilla values ± SE for the OPN constructs /EV (left to right) were: 13.5 ± 3, 28.66 ± 2.8, 55.3 ± 3, 97 ± 5.8, 34.85 ± 4, 42.86 ± 1, 54 ± 7.9, and 46.7 ± 1.5, respectively. Note that the 2 mutant constructs with altered 3’ half-sites are no longer responsive to ePi addition. These experiments were performed in triplicate and represent 1 of 3 experiments. *P ≤ 0.05.
Figure 4.
Figure 4.
Effects of dexamethasone and RU-486 on OPN promoter activity. OCCM-30 cells were transfected with the indicated plasmids (4 µg/60 mm dish) and then incubated with Pi (ePi), dexamethasone, and/or RU-486, and luciferase assays were performed as described in MATERIALS & METHODS. Firefly luciferase activity is shown normalized to Renilla luciferase. (A) OPN promoter activity in the presence of dexamethasone and Pi. Cells were transfected with; pGL3-Control (C), empty vector (EV), or -1454/+ 5 OPN-luc (OPN-luc), followed by treatment with 3 mM Pi and/or 1 mM dexamethasone (DEX) as indicated. Mean Firefly/Renilla values ± SE for the OPN constructs/EV (left to right) were: 152 ± 5.2, 221 ± 38.7, 221 ± 38.7, and 228 ± 32.8. (B) GRE-luc promoter activity in the presence of dexamethasone and Pi. Cells were transfected with GR-luc and then treated with Pi, dexamethasone, or dexamethasone and Pi. Mean Firefly/Renilla values ± SE for the GR construct/EV (left to right) were: 7.21 ± 0.75, 5.6 ± 0.13, 61.43 ± 10.08, and 49.9 ± 8.55, respectively. (C) OPN promoter activity in the presence of 3mM Pi and RU-486 (100 nM-1 µM). Cells were transfected with pGL3-Control (C), empty vector (EV), or -1454/+ 5 OPN-luc (OPN-luc) and then treated with Pi, or Pi and RU-486 as indicated. Mean Firefly/Renilla values ± SE for the OPN constructs/EV (left to right) were: 7.7 ± 0.4, 18.46 ± 0.7, 11.57 ± 2.2, and 9.06 ± 0.5, respectively. (D) GRE-luc promoter activity in the presence of dexamethasone and RU-486 (100 nM and 1 mM). Cells were transfected with GR-luc and then treated with dexamethasone, or dexamethasone and RU-486 (100 nM and 1 mM). Mean Firefly/Renilla values ± SE for the GR constructs/EV (left to right) were: 1.47± 0.19, 9.84 ± 0.9, 2.9 ± 0.9, and 1.84 ± 0.5, respectively. *P ≤ 0.05.

References

    1. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860-864 - PubMed
    1. Beck GR., Jr (2003). Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90:234-243 - PubMed
    1. Beck GR, Jr, Knecht N. (2003). Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278:41921-41929 - PubMed
    1. Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD. (2002). Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71:145-154 - PubMed
    1. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, Yu LR, et al. (2005). A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol Cell Proteomics 4:1284-1296 - PubMed

Publication types

MeSH terms